ClinVar Miner

Submissions for variant NM_000350.3(ABCA4):c.838A>T (p.Met280Leu)

gnomAD frequency: 0.00183  dbSNP: rs138682163
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000255612 SCV000321333 uncertain significance not provided 2016-05-19 criteria provided, single submitter clinical testing The M280L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The NHLBI Exome Sequencing Project reports M280L was observed in 20/4406 (0.45%) alleles from individuals of African American background, and the 1000 Genomes Project Consortium reports M280L was observed in 10/1322 (0.76%) alleles from individuals of African background indicating it may be a rare variant in this population. The M280L variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. A missense variant in the same residue (M280T) has been reported in the Human Gene Mutation Database in association with Stargardt disease (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant.
Fulgent Genetics, Fulgent Genetics RCV000764206 SCV000895209 uncertain significance Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 2018-10-31 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000255612 SCV001031259 likely benign not provided 2025-01-08 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004542963 SCV004782387 likely benign ABCA4-related disorder 2022-04-06 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.